Corbus Pharmaceuticals Holdings Inc (CRBP)
37.54
+0.51
(+1.38%)
USD |
NASDAQ |
May 01, 16:00
37.54
0.00 (0.00%)
After-Hours: 18:18
Corbus Pharmaceuticals Holdings Cash and Short Term Investments (Quarterly): 20.91M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 20.91M |
| September 30, 2023 | 28.73M |
| June 30, 2023 | 36.57M |
| March 31, 2023 | 44.23M |
| December 31, 2022 | 59.20M |
| September 30, 2022 | 66.23M |
| June 30, 2022 | 73.30M |
| March 31, 2022 | 86.12M |
| December 31, 2021 | 97.65M |
| September 30, 2021 | 106.86M |
| June 30, 2021 | 106.45M |
| March 31, 2021 | 124.01M |
| December 31, 2020 | 85.43M |
| September 30, 2020 | 81.87M |
| June 30, 2020 | 63.47M |
| March 31, 2020 | 46.62M |
| December 31, 2019 | 31.75M |
| September 30, 2019 | 54.85M |
| June 30, 2019 | 73.15M |
| March 31, 2019 | 89.92M |
| Date | Value |
|---|---|
| December 31, 2018 | 41.75M |
| September 30, 2018 | 55.66M |
| June 30, 2018 | 64.68M |
| March 31, 2018 | 70.96M |
| December 31, 2017 | 62.54M |
| September 30, 2017 | 36.60M |
| June 30, 2017 | 43.03M |
| March 31, 2017 | 48.93M |
| December 31, 2016 | 14.99M |
| September 30, 2016 | 18.91M |
| June 30, 2016 | 22.02M |
| March 31, 2016 | 9.688M |
| December 31, 2015 | 12.34M |
| September 30, 2015 | 13.17M |
| June 30, 2015 | 9.243M |
| March 31, 2015 | 4.972M |
| December 31, 2014 | 6.262M |
| September 30, 2014 | 7.536M |
| December 31, 2013 | 0.303M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
20.91M
Minimum
Dec 2023
124.01M
Maximum
Mar 2021
67.76M
Average
66.23M
Median
Sep 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Spectral AI Inc | 7.348M |
| Panbela Therapeutics Inc | 2.578M |
| AIM ImmunoTech Inc | 13.07M |
| Protalix BioTherapeutics Inc | 44.56M |
| Armata Pharmaceuticals Inc | 13.52M |